Insider Transactions in Q3 2022 at Harvard Bioscience Inc (HBIO)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 06
2022
|
Bertrand Loy Director |
SELL
Other acquisition or disposition
|
Indirect |
108,715
-100.0%
|
-
|
|
Aug 26
2022
|
Bertrand Loy Director |
BUY
Open market or private purchase
|
Direct |
9,291
+2.27%
|
$27,873
$3.41 P/Share
|
|
Aug 25
2022
|
Bertrand Loy Director |
BUY
Open market or private purchase
|
Direct |
8,244
+2.07%
|
$24,732
$3.34 P/Share
|
|
Aug 24
2022
|
Bertrand Loy Director |
BUY
Open market or private purchase
|
Direct |
17,291
+4.33%
|
$51,873
$3.23 P/Share
|
|
Aug 23
2022
|
Bertrand Loy Director |
BUY
Open market or private purchase
|
Direct |
8,939
+2.39%
|
$26,817
$3.23 P/Share
|
|
Aug 22
2022
|
Bertrand Loy Director |
BUY
Open market or private purchase
|
Direct |
4,918
+1.36%
|
$14,754
$3.16 P/Share
|
|
Aug 19
2022
|
Bertrand Loy Director |
BUY
Open market or private purchase
|
Direct |
9,608
+2.66%
|
$28,824
$3.28 P/Share
|
|
Aug 18
2022
|
Bertrand Loy Director |
BUY
Open market or private purchase
|
Direct |
1,151
+0.34%
|
$3,453
$3.19 P/Share
|
|
Aug 17
2022
|
James W Green Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+1.75%
|
$120,000
$3.19 P/Share
|
|
Jul 18
2022
|
Michael A. Rossi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,008
-2.53%
|
$21,024
$3.63 P/Share
|
|
Jul 08
2022
|
James W Green Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
92,771
-4.03%
|
$278,313
$3.9 P/Share
|